Empagliflozin vs Ocrelizumab

## Empagliflozin vs Ocrelizumab: Overview

This comparison examines the pharmacological differences between **Empagliflozin** and **Ocrelizumab**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

## Pharmacokinetics

**Half-life**: Empagliflozin — 12.4 hours; Ocrelizumab — N/A.

## Chemical Properties

**Molecular Formula**: Empagliflozin — C23H27ClO7; Ocrelizumab — N/A.

**Molecular Weight**: Empagliflozin — 450.9100 g/mol; Ocrelizumab — N/A.

**Type**: Empagliflozin — Small molecule; Ocrelizumab — Antibody.